J.P. Morgan Healthcare Conference Jan 8-11, 2024

Jan 10, 2024

It’s great to be here reconnecting with so many colleagues and discussing new viral vector opportunities. The ViroCell Biologics team looks forward to discussing how we can support your near-term lentivirus or gamma-retro viral vector needs.

John W. Hadden II, CEO, ViroCell

#jpm2024 #jpmorganhealthcareconference Traci Kyes Brian Collins #viralvectors #biotech #genetherapy #celltherapy #cellandgenetherapy #clinicaltrials #cdmo #sanfrancisco

Florence Buchanan